Medical Health Cluster


Factors Influencing COVID-19-Related Mortality Risk in T2DM Patients

Takeaway Several factors are likely to influence the risk of subsequent COVID-19-related mortality in patients with type 2 diabetes mellitus (T2DM) following a confirmed COVID-19 infection. The use of metformin, sodium-glucose co-transporter 2 inhibitors (SGLT2is), and glucagon-like peptide 1 (GLP-1) agonists and a non-smoking status were associated with a lower […]

Read More